DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/560cfc/pancreatic_cancer) has announced the addition of the "Pancreatic Cancer Drugs - Global Strategic Business Report" report to their offering.
This report analyzes the Global market for Pancreatic Cancer Drugs in US$ Million. Annual forecasts are provided for the period 2006 through 2015. The report profiles 57 companies including Abraxis BioScience, Inc., Amgen, Inc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd.., Genentech Inc., and OSI Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
II. Executive Summary
1. MARKET REVIEW
2. PANCREATIC CANCER - THE STUDY OF A FATAL DISEASE
3. RESEARCH & DEVELOPMENT
4. RECENT INDUSTRY ACTIVITY
5. REGULATORY SUBMISSIONS AND APPROVALS
6. FOCUS ON SELECT PLAYERS
7. GLOBAL MARKET PERSPECTIVE
III. COMPETITIVE LANDSCAPE
Total Companies Profiled: 57 (including Divisions/Subsidiaries - 61)
Region/Country Players
The United States 37
Canada 2
Japan 5
Europe 12
France 1
Germany 5
The United Kingdom 1
Spain 1
Rest of Europe 4
Asia-Pacific (Excluding Japan) 4
Middel East 1
Companies Mentioned:
- Abraxis BioScience, Inc. (USA)
- Amgen, Inc. (USA)
- Eli Lilly and Company (USA)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Genentech Inc. (USA)
- OSI Pharmaceuticals, Inc. (USA)
For more information visit http://www.researchandmarkets.com/research/560cfc/pancreatic_cancer
CONTACT:
Research and Markets
Laura Wood, Senior Manager
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
KEYWORDS:
INDUSTRY KEYWORDS: Health Oncology Pharmaceutical
MEDIA:
| Logo |